United Therapeutics Corporation

United Therapeutics Corporation price momentum is very positive. United Therapeutics Corporation has good value characteristics. United Therapeutics Corporation is not very popular among insiders. United Therapeutics Corporation is a good stock to invest in, but there are better stocks to choose.
Log in to see more information.
United Therapeutics Corp. operates as a biotechnology company, which engages in the development and...

News

James Edgemond Sells 7,802 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock
James Edgemond Sells 7,802 Shares of United Therapeutics Co. (NASDAQ:UTHR) Stock

Ticker Report United Therapeutics Co. (NASDAQ:UTHR - Get Free Report) CFO James Edgemond sold 7,802 shares of the company's stock in a transaction on Monday, September 9th. The shares were sold at an average price...\n more…

United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Acadian Asset Management LLC
United Therapeutics Co. (NASDAQ:UTHR) Shares Sold by Acadian Asset Management LLC

Ticker Report Acadian Asset Management LLC trimmed its position in United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 79.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 22,590 shares of...\n more…

United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left BehindEver
United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left BehindEver

Business Wire United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation (PBC), today announced the release of its 2024 Corporate Responsibility and Public Benefit Report (Report) covering its FY...\n more…

Savant Capital LLC Cuts Stock Position in United Therapeutics Co. (NASDAQ:UTHR)
Savant Capital LLC Cuts Stock Position in United Therapeutics Co. (NASDAQ:UTHR)

Ticker Report Savant Capital LLC trimmed its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 1.2% in the second quarter, according to its most recent filing with the Securities and...\n more…

Arizona State Retirement System Has $3.91 Million Stake in United Therapeutics Co. (NASDAQ:UTHR)
Arizona State Retirement System Has $3.91 Million Stake in United Therapeutics Co. (NASDAQ:UTHR)

Ticker Report Arizona State Retirement System decreased its position in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 5.0% during the 2nd quarter, HoldingsChannel reports. The fund owned 12,281...\n more…

CIBC Asset Management Inc Has $490,000 Holdings in United Therapeutics Co. (NASDAQ:UTHR)
CIBC Asset Management Inc Has $490,000 Holdings in United Therapeutics Co. (NASDAQ:UTHR)

Ticker Report CIBC Asset Management Inc increased its stake in shares of United Therapeutics Co. (NASDAQ:UTHR - Free Report) by 17.9% in the 2nd quarter, according to its most recent 13F filing with the Securities...\n more…